1435 Capital · New Jersey
Garden State Innovation Fund
Investing early in New Jersey-based, technology-driven startups — Seed and Series A opportunities with validated market traction.
01 — Underlying thesis
Capturing outsized growth, early.
The Garden State Innovation Fund is built on a core thesis of capturing outsized growth by investing early in New Jersey-based, technology-driven startups, with a focus on Seed and Series A opportunities that have validated market traction. The fund combines two proven high-return approaches of 1435 Capital—early-stage venture (‘post-traction’ entry at Seed/Series A) and New Jersey-focused investing—into a single vehicle designed to maximize risk-adjusted venture returns
Early Entry at Inflection Points
The fund targets companies at the “inflection point” where product-market fit is established, and growth is accelerating. This timing reduces the volatility and high failure rates of very early-stage (pre-seed/angel), but captures more upside before major valuation step-ups
New Jersey as an Under-Tapped Ecosystem
New Jersey is described as an “untapped and flourishing” innovation market, with the state generating 14 unicorns between 2019-2024, major tech IPOs (e.g., CoreWeave, eToro), a rapidly increasing pool of venture-attractive startups, and enormous growth in foreign investment
Sector Diversity and Capital Efficiency
The fund avoids over-concentration by investing across sectors (excluding capital-intensive biotech), and focuses on capital-efficient business models and strong founding team
Value Creation Through Local Ecosystem Ties
Deep relationships with NJEDA, top universities (Princeton, Rutgers, Stevens), founder networks, and innovation hubs provide proprietary deal flow and enable early access to emerging talent and companies
02 — The opportunity
Let’s Make It Happen In New Jersey, Baby
Rebound in Venture Activity & Strong Early-Stage Performance
Venture capital activity rebounded in 2024–2025, and early-stage deals saw stronger capital flows and exit momentum than later-stage deals. 1435 Capital’s track record in Seed and Series A investing, and in New Jersey-focused investments in particular, points to several paths to attractive long-term returns.
NJ’s Strategic Advantages Are Converging
- Critical mass of innovation hubs like HELIX, HAX, and the AI Hub.
- Over $1B in public/private capital catalyzed by NJEDA.
- State-supported investment programs (Evergreen Fund, Angel Tax Credit) create material leverage and de-risk initial capital via matching and refundable credits.
- Lower cost base (~30–50% less than NYC) allows capital to stretch further, supporting longer runway for growth.
03 — Why it matters
Why it matters for the NJ startup ecosystem.
01
Catalyzing Local Innovation
The fund injects critical capital at the point where NJ startups demonstrate traction, accelerating their path to scale and attracting further outside investment.
02
Amplifying Impact with State Backing
Leveraging NJEDA matching and tax incentives directly boosts round sizes and adds credibility, drawing more founders and out-of-state capital to NJ deals.
03
Strengthening Community Ties
The fund’s active involvement—mentorship, board observation, and operational support—translates into better founder outcomes and knowledge transfer, multiplying the capacity of the local ecosystem.
04
Pipeline Development
1435’s university and founder relationships ensure visibility into the most promising next-gen startups, while anchor NJ institutions increase the vibrancy and sustainability of the ecosystem
04 — Investment team
Investment team.
05 — Learn more
Request fund information.
Leave your name and email and a member of the team will follow up.
Disclaimer / Forward Looking Statement
All statements contained in this Presentation, statements made in related documents and oral statements that may be made by the Company or its Directors, partners or employees, that are not statements of historical fact, constitute “forward-looking statements”. Some of these forward-looking statements are identified by terms such as “anticipate”, “believe”, “could”, “estimate”, “expect”, “intend”, “may”, “plan”, “predict”, “will”, and “would” or similar words and phrases. However, these words are not the exclusive means of identifying forward-looking statements. All statements regarding the Company’s expected financial position, trend information, strategies, business plans and prospects are forward-looking statements.
These forward-looking statements, including without limitation, statements as to: (a) revenue and profitability; (b) expected growth; (c) expected industry trends; (d) anticipated expansion and development plans; and (e) other matters discussed regarding matters that are not historical fact, are only predictions. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements expected, expressed or implied by these forward-looking statements. These risks, uncertainties and other factors include, among others: (a) the effects of competition in the geographic and business areas in which the Company conducts its operations; (b) the effects of changes in laws, regulations, taxation or accounting standards or practices; (c) acquisitions, divestments and various business opportunities that the Company may pursue; and (d) the effects of changes in international political, social and economic events on our businesses. This list of important factors is not exhaustive. All forward-looking statements made by or attributable to the Company, or persons acting on its behalf, are expressly qualified in their entirety by such factors. These forward-looking statements are applicable only as of the date of this Presentation. Given the risks and uncertainties that may cause the Company’s actual future results, performance or achievements to be materially different from those expected, expressed or implied by the forward-looking statements in this Presentation, undue reliance should not be placed on those statements. The Company does not represent or warrant that actual future results, performance or achievements will be as discussed in those statements. The Company disclaims any responsibility to update any of those forward-looking statements any revisions to those forward-looking statements to reflect future developments, events or circumstances for any reason, even if new information becomes available or other events occur in the future.
You should seek independent counsel before making any investment decisions. May lose value. Not a recommendation to buy securities.


